Local treatment of rheumatic diseases with the 5-HT3 receptor antagonist tropisetron;Lokalbehandlung rheumatischer erkrankungen mit dem 5-HT3-rezeptor-antagonisten tropisetron

Schmerz

Volumn 17, Issue 3, 2003, Pages 200-203

  Stratz, Th ^a   Muller W ^a  

^a Hochrhein Inst fur Rehab Forsch   (Germany)

Author keywords

5 HT3 receptor antagonist; Analgesia; Antiphlogistic agents; Diseases of the locomotor system; Tropisetron

Indexed keywords

ANTIINFLAMMATORY AGENT; LIDOCAINE; PRILOCAINE; SEROTONIN 3 ANTAGONIST; TROPISETRON;

ANALGESIA; HUMAN; MYOFASCIAL PAIN; NONHUMAN; PERIARTHRITIS; REVIEW; RHEUMATIC DISEASE; TENDON DISEASE;

EID: 0038804148     PISSN: 0932433X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00482-003-0219-9     Document Type: Review

References (23)

1. Ambesh SP, Dubey PK, Sinha PK (1999) Ondan setron pretreatment to alleviate pain on propofol injection: a randomized, controlled, double-blind study. Anesth Analg 89: 197-199
2. Arnalich F, Miguel E de, Perez-Ayala C, Martinez M, Vasquez JJ, Gijon-Banos J, Hernanz A (1994) Neuropeptides and interleukin-6 in human joint inflammation; relationship between intraarticular substance P and interleukin-6 concentration. Neurosci Lett 170:251-254
3. Färber L, Stratz T, Brückle W, Späth M, Pongratz D, Lautenschläger J, Kötter I, Zöller B, Peter HH, Neeck R, Alten R, Müller W (2000) Efficacy and tolerability of tropisetron in primary fibromyalgia - a highly selective and competitive 5-HT3 receptor antagonist. Scand J Rheumatol [Suppl 113] 29: 49-54
4. Ferrell WR, Russell NJ (1986) Extravasation in the knee induced by antidromic stimulation of articular C fibre afferents of the anaesthetized cat. J Physiol (Lond) 379: 407-416
5. Giordano J, Rogers LV (1989) Peripherally administered serotonin 5-HT3 receptor antagonists reduce inflammatory pain in rats. Eur J Pharmacol 170: 83-86
6. Giordano J, Daleo C, Sacks SM (1989) Topical ondansetron attenuates nociceptive and inflammatory effects of intradermal capsaicin in humans. Eur J Pharmacol 354: 13-14
7. Glaum SR, Proudfit HK, Andersen EG (1990) 5-HT3-receptors modulate spinal nociceptive reflexes. Brain Res 510: 12-16
8. Greenshaw AJ, Silverstone PH (1997) The non-anti-emetic uses of serotonin 5-HT3-receptor antagonists. Drug 55: 20-39
9. Holzer P (1992) Peptidergic sensory neurons in the control of vascular functions: mechanisms and significance in the cutaneous and splanchnic vascular beds. Rev Physiol Biochem Pharmacol 121: 49-149
10. Inoue A, Hashimoto T, Hide I, Nishio H, Nkata Y (1997) 5-hydroxytrytamine-facilitated release of substance P from rat spinal cord slices is mediated by nitric oxide and cyclic GMP. J Neurochem 68:128-133
11. + influx in human T cells: role in T cell activation. J Neuroimmunol 99: 53-60
12. Levine JD, Clark R, Devor M, Helms C, Moskowitz MA, Basbaum AI (1984) Intraneuronal substance P contributes to the severity of experimental arthritis. Science 226: 547-549
13. Lotz M, Carson DA, Vaughan JH (1987) Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. Science 235: 893-895
14. Menkes CJ, Renoux M, Laoussadi S, Mauborgne A, Bruxelle J, Cesselin F (1993) Substance P levels in the synovium fluid from patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 20: 714-717
15. Müller W, Stratz T, Schochat T, Mennet P (1994) Die Therapie der Fibromyalgie mit 5-HT3-Rezeptor-Antagonisten. Z Rheumatol [Suppl 1] 53: 24
16. Richardson BP, Engel G, Donatsch P, Stadler PA (1985) Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316: 126-131
17. Saria A, Javorsky F, Humpel C, Gamse R (1990) 5-HT3-receptor antagonists inhibit sensory neuropeptide release from the rat spinal cord. Neuroreport 1: 104-106
18. Stratz T, Müller W (2000) The use of 5-HT3 receptor antagonists in various rheumatic diseases - a clue to the mechanism of action in these agents in fibromyalgia? Scand J Rheumatol [Suppl 113] 29: 66-71
19. Stratz T, Müller W (2002) Die Schmerzbeeinflussung durch den 5-HT3-Rezeptorantagonisten Tropisetron bei sekundären Fibromyalgien. Fortschr Med 120: 17-20
20. Stratz T, Schochat T, Hrycaj P, Lacki J, Mennet P, Färber L, Schweiger C, Müller W (1994) Die Therapie der generalisierten Tendomyopathie (Fibromyalgie) durch Blockierung der 5-HT3-Rezeptoren. Z Rheumatol 53: 225-338
21. Stratz T, Färber L, Müller W (2002) Local treatment of tendinopathies: a comparison between tropisetron and depot corticosteroids combined with local anesthetics. Scand J Rheumatol 31: 366-370
22. Stratz T, Urbaniak M, Lacki JK, Mackiewicz S, Reichelt A, Müller W (2002) Intra-articular injection of tropisetron in osteoarthrosis with inflammatory reactions. Ann Rheum Dis [Suppl 1] 61: 420
23. Stratz T, Varga B, Müller W (2002) Treatment of tendopathies with tropisetron. Rheumatol Int 22: 219-221